Back to Search
CLIFFORD HUDIS, MD
MD
Medical Oncology Physician
NPI: 1811090715IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
170023(NY)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
MEDICAL COLLEGE OF PENNSYLVANIA
Class of 1983
Research & Publications (20)
Current status of the taxanes as adjuvant therapy for breast cancer.
PMID 17723302·Breast·2007
6-review
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.
PMID 17513820·J Clin Oncol·2007
8-other
Trastuzumab--mechanism of action and use in clinical practice.
PMID 17611206·N Engl J Med·2007
6-review
Cancer and leukemia group B breast committee: decades of progress and plans for the future.
PMID 16740788·Clin Cancer Res·2006
6-review
Trastuzumab adds to adjuvant chemotherapy for resected HER2-positive breast cancer.
PMID 16407871·Nat Clin Pract Oncol·2006
8-other
Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life.
PMID 16001991·Clin Breast Cancer·2005
3-trial
The best use of adjuvant chemotherapy: new drugs and new use of "old" drugs.
PMID 16183287·Breast·2005
6-review
Clinical implications of antiangiogenic therapies.
PMID 15934500·Oncology (Williston Park)·2005
6-review
Current status and future directions in breast cancer therapy.
PMID 14667277·Clin Breast Cancer·2003
6-review
Single-agent vs combination therapy in advanced breast cancer: potential roles of capecitabine.
PMID 12435174·Oncology (Williston Park)·2002
4-observational
Adjuvant use of taxanes for patients with breast cancer: we see the tip of the iceberg.
PMID 12533262·Clin Breast Cancer·2002
6-review
Anthracyclines and trastuzumab; getting to the heart of the matter: when getting to the heart is the matter.
PMID 18791822·Breast Cancer Res Treat·2011
8-other
Therapeutic options for metastatic breast cancer.
PMID 19351274·Expert Opin Pharmacother·2009
6-review
Phase I study of nonpegylated liposomal doxorubicin plus trastuzumab in patients with HER2-positive breast cancer.
PMID 19433391·Clin Breast Cancer·2009
3-trial
Adjuvant chemotherapy in older women with early-stage breast cancer.
PMID 19439741·N Engl J Med·2009
4-observational
Latent bone metastasis in breast cancer tied to Src-dependent survival signals.
PMID 19573813·Cancer Cell·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-2000
Quick Facts
- NPI
- 1811090715
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile